HEIDELBERG, Germany, Nov 17 (Bernama-PRNewswire) — European Wellness Academy (EWA), a member of European Wellness Biomedical Group (EWBG), recently signed its second research contract involving General In Vitro/In Vivo Safety and Toxicity Tests for Preclinical Studies of Regenerative Peptides with Heidelberg University.
The research contract signed is a continuation of the previous research on the efficacy of the Group’s cutting-edge biotherapeutics including precursor (progenitor) stem cells (PSC), precursor cells (Frozen Organo Crygenics (FOC)), Mito Organelles (MO), Nano Organo Peptides (NOP) and exosomes.
- UN body warns over US Pres Trump’s deep-sea mining order
- World’s oldest person, a Brazilian nun, dies aged 116
- Jordan Handed Down 20-Year Sentences In National Security Case
- Houthis Say Their Attacks Led To Downing Of U.S. F-18 Fighter Jet
- Zanzibar to host landmark world freight forwarders summit
- DPRK’s New-Generation Destroyer Conducted First Weapon Systems Test
- Iran Says 4th Round Of Indirect Talks With U.S. Set For Rome
- Pakistani Army Accuses India Of Sponsoring Terrorism, Presents “Irrefutable Evidence”
- Syrian Authorities, Local Leaders Reach Deal To End Sectarian Clashes Near Damascus
- Lebanese President Reaffirms Commitment To Reforms, Urges U.S. Pressure On Israel To Withdraw